Skip to content
Serodus
  • About Serodus
    • Board of directors
    • Management
    • Advisors
  • Diseases
  • Pipeline
    • SER150
    • SER130
  • Partnering
  • Investor
    • Financial Calendar
    • Presentations
    • Prospectus
    • Publications
    • Quarterly Reports
    • Annual Reports
    • General Meeting
    • Article of Association
    • Why Invest
    • Corporate governance
  • News
  • Contact
Menu Close

2023-02 – Q4 2022 Reporting

  • Post author:seroadmin
  • Post published:02-02-2023
  • Post category:News

New Zealand authorities approved the protocol with dosing of SER150 or placebo for six months. All clinical centers in Australia and New Zealand ready to initiate screening of patients in…

Continue Reading2023-02 – Q4 2022 Reporting

2023-01 – New CEO in Serodus ASA

  • Post author:seroadmin
  • Post published:17-01-2023
  • Post category:News

Serodus ASA’s Board of Directors has in agreement with our CEO Eva Steiness decided to relieve her for the administrative burden to manage Serodus ASA from her permanent address in…

Continue Reading2023-01 – New CEO in Serodus ASA

2022-07 – Serodus ASA – Minutes of Annual General Meeting 2022

  • Post author:seroadmin
  • Post published:05-07-2022
  • Post category:News

Download: Presentation AGM 2022 Download: Minutes from General Meeting

Continue Reading2022-07 – Serodus ASA – Minutes of Annual General Meeting 2022

2022-05 – 2021 Annual Report

  • Post author:seroadmin
  • Post published:05-05-2022
  • Post category:News

SERODUS ASA - Publishes 2021 Annual Report Download it here

Continue Reading2022-05 – 2021 Annual Report

Serodus ASA

Heia 8
N-0268 Oslo
Norway

Mail: post@serodus.com

News

Sign up below to receive our newsletters.
Close Menu
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT